Business Context and Reporting Period
Company: Anteris Technologies Global Corp. (AVR)
Filing Type: Form 8-K (Current Report)
Date of Report: January 22, 2026
Reporting Period: Event date January 22, 2026 (Stock Purchase Agreement dated January 20, 2026)
The Company is an emerging growth company incorporated in Delaware with principal executive offices in Toowong, Australia. This filing discloses a strategic investment event under Regulation FD.
Key Financial Metrics
This Form 8-K is an event-driven report and does not contain periodic financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
- Strategic Investment: Anteris Technologies Global Corp. announced a strategic investment from Medtronic plc (through a wholly owned subsidiary).
- Agreement Details: The transaction is governed by a stock purchase agreement dated January 20, 2026.
- Announcement: A joint press release was issued on January 22, 2026, detailing the partnership.
Guidance, Outlook, and Risks
Management Commentary: The filing references a joint press release (Exhibit 99.1) regarding the strategic investment but does not include specific forward-looking guidance, financial outlook, or detailed risk factors within the body of this 8-K text.
Unusual Items: The primary unusual item is the entry into a material agreement with a major medical technology firm (Medtronic), which may impact future capital structure and strategic direction.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific investment amounts, share counts, and valuation details not included in the 8-K summary.
- Verify the terms of the Stock Purchase Agreement dated January 20, 2026, including any conditions precedent or closing requirements.
- Assess the impact of Medtronic's investment on Anteris's capitalization table and potential dilution to existing shareholders.
- Monitor subsequent filings for any definitive agreements or amendments to the initial stock purchase agreement.